Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |